The present disclosure provides apparatuses and methods for analyzing the presence of a target analyte. The apparatuses and methods of the present disclosure can be operated in a multiplexed format to perform various assays of clinical significance.

The optical interrogation technique can use an optical prism having two opposite sides including a sample side and a refraction side, the sample side having a plurality of interrogation areas; a source assembly generating a collimated field of illumination directed towards the refraction side; a screen disposed in a screen plane intersecting the field of illumination and shielding the refraction side from the field of illumination, the screen having an aperture allowing a portion of the field of illumination to reach and be refracted by the refraction side, be totally internally reflected at one of said interrogation areas of the sample side, thereby generating a signal, the signal refracted back through the aperture, the screen being movable within the screen plane to shift the aperture and expose different portions of the field of illumination to corresponding ones of the interrogation areas.

The optical interrogation technique can use an optical prism having two opposite sides including a sample side and a refraction side, the sample side having a plurality of interrogation areas; a source assembly generating a collimated field of illumination directed towards the refraction side; a screen disposed in a screen plane intersecting the field of illumination and shielding the refraction side from the field of illumination, the screen having an aperture allowing a portion of the field of illumination to reach and be refracted by the refraction side, be totally internally reflected at one of said interrogation areas of the sample side, thereby generating a signal, the signal refracted back through the aperture, the screen being movable within the screen plane to shift the aperture and expose different portions of the field of illumination to corresponding ones of the interrogation areas.

A biological sensing apparatus includes an optical waveguide substrate, a surface plasmon resonance (SPR) layer, and a lossy mode resonance (LMR) layer. The optical waveguide substrate includes a light input end and a light output end opposite to each other, and a biological sensing area is formed on one surface of the optical waveguide substrate between the light input end and the light output end. The SPR layer includes a metal layer and a plurality of biological probes. The metal layer is arranged on part of the biological sensing area, and the plurality of biological probes are evenly arranged on the metal layer. The LMR layer is arranged on part of the biological sensing area, and the LMR layer and the SPR layer are not overlapped. The present disclosure further includes a biological sensing system and a method of using the same.

Disclosed are systems and methods of label-free detecting cellular physiological activities involving monitoring local refractive index changes associated with cellular physiological activities using a single ultracompact light emitting diode (LED) chip serving as a refractometer.

The present invention relates to a method for production of an improved sensor surface for an SPR instrument, comprising forming a self assembled monolayer (SAM) on a surface and attaching ligands and protein resistant groups, preferably polyethylene glycol (PEG), directly to functional groups on said surface. The invention also relates to a sensor surface produced by these methods use thereof in SPR (surface plasmon resonance) assays or interactions.

The present disclosure provides a method for determining of aggregates comprising one or more macromolecules, in a first sample potentially comprising aggregates of the macromolecule(s), comprising the steps of (a) contacting a first sample with a sensing surface of an interaction analysis sensor, said sensing surface having immobilised thereon a ligand comprising a hydrophobic group, which is capable of increased binding interaction with aggregates of macromolecule(s) compared to non-aggregated macromolecule(s); (b) determining at least one parameter for the interaction of the first sample with the sensing surface; (c) Performing at least one of steps (i) and (ii): (i) Comparing the at least one parameter determined in step (b) with the corresponding parameter(s) determined for at least one additional sample potentially comprising aggregates of the macromolecule(s); (ii) determining at least one parameter related to aggregate(s) of the macromolecule(s); and (d) determining the presence, fraction, concentration, and/or amount of macromolecule(s) in the form of aggregate(s) in the first sample. The present disclosure also relates to uses of said method and an interaction analysis sensor for use in said method, as well as an interaction analysis sensor and a method for determining of the stability of a macromolecule.

A biological component measurement apparatus includes an optical medium, an excitation light source, a probe light source, and a light position detector. The optical medium includes a sample placement surface. The excitation light source emits excitation light toward a sample placed on the sample placement surface. The probe light source emits probe light that travels through the optical medium. The light position detector detects the position of the probe light outgoing from the optical medium. The optical medium is formed from chalcogenide glass.

A spectroscopic measurement device includes: a light source unit configured to output pump light and probe light; a terahertz wave generation unit configured to generate a terahertz wave by the input of the pump light; a terahertz wave detection unit to which the terahertz wave and the probe light are input and configured to modulate the probe light based on a refractive index that changes due to an electro-optical effect according to the input of the terahertz wave; and a light detection unit configured to detect the probe light modulated by the terahertz wave detection unit. A main body unit is configured to include the light source unit and the light detection unit. A measurement unit is configured to include the terahertz wave generation unit and the terahertz wave detection unit. The main body unit and the measurement unit are optically connected to each other by a polarization maintaining fiber.

Aspects relate to a spectroscopic analyzer device that can be used for biological sample detection, and specifically for virus infection detection. The spectroscopic analyzer device includes a spectrometer, such as a micro-electro-mechanical systems (MEMS) based infrared spectrometer, and an artificial intelligence (AI) for screening of viral samples. In addition, the spectroscopic analyzer device includes a light source and a disposable optical component configured to receive a sample and to facilitate light interaction with the sample.